These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 11317198)
21. Gingival enlargement in antihypertensive medication. Pradhan S; Mishra P JNMA J Nepal Med Assoc; 2009; 48(174):149-52. PubMed ID: 20387357 [TBL] [Abstract][Full Text] [Related]
22. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839 [TBL] [Abstract][Full Text] [Related]
23. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J; Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936 [TBL] [Abstract][Full Text] [Related]
24. Antihypertensive drug-associated sexual dysfunction: a prescription analysis-based study. al Khaja KA; Sequeira RP; al Damanhori AH; Mathur VS Pharmacoepidemiol Drug Saf; 2003; 12(3):203-12. PubMed ID: 12733473 [TBL] [Abstract][Full Text] [Related]
25. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
26. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
27. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study. Lindberg G; Lindblad U; Löw-Larsen B; Merlo J; Melander A; Råstam L Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):493-7. PubMed ID: 12426934 [TBL] [Abstract][Full Text] [Related]
28. [Arterial hypertension management in patients with type 2 diabetes]. Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076 [TBL] [Abstract][Full Text] [Related]
29. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
30. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents. Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574 [TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
32. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Roberts ME; Epstein BJ J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098 [TBL] [Abstract][Full Text] [Related]
33. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. Rejnmark L; Vestergaard P; Mosekilde L J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662 [TBL] [Abstract][Full Text] [Related]
34. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project. Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
36. Use of antihypertensives and the risk of Parkinson disease. Becker C; Jick SS; Meier CR Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367 [TBL] [Abstract][Full Text] [Related]
37. Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Blumentals WA; Brown RR; Gomez-Caminero A Int J Impot Res; 2003 Oct; 15(5):314-7. PubMed ID: 14562130 [TBL] [Abstract][Full Text] [Related]
38. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546 [TBL] [Abstract][Full Text] [Related]
39. Risk of falls associated with antihypertensive medication: self-controlled case series. Gribbin J; Hubbard R; Gladman J; Smith C; Lewis S Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):879-84. PubMed ID: 21744415 [TBL] [Abstract][Full Text] [Related]